This Year’s Theme: How to Globalize Asia Innovation 

From China and Japan, to South Korea and Singapore, Asia biotechs must globalize to succeed. Many are licensing global rights to Western biopharmas. Others are pursuing the "Newco Model," partnering with Western investors to launch new biotechs in the U.S. or Europe.

At the 4th East-West Summit, you will meet key players looking to globalize innovation from across Asia.

See for yourself: Join us for two days of C-level networking, partnering and debate, tailored for VCs, CEOs, CFOs, CBOs and decision-makers driving biopharma innovation in Asia and the West.

What Will I Learn?

Highlights:

Globalizing Asian Innovation: The BioCentury Scene Setter asks whether routing Asia assets to the West can be sustained, and will it result in more Asia biotechs?

The NewCo Model: The Investor Roundtable asks whether Western and Asia investors see NewCos as the best path forward to globalizing Asia's innovation?

Pharma Licensing: The Dealmakers Showcase asks pharma BD&L leaders if the wave of licensing from Asia is here to stay.

AND MUCH MORE: VIEW PRELIMINARY AGENDA >>

Why Should I Attend?

The East-West Summit is a premier C-level conference for Asian and Western biopharma executives and investors: Expand your network, debate strategy, find the right partner.

Network, partner and debate with:

• VCs and PEs
• Biopharma BD&L Leaders
• Biotech C-Suite
• Family Offices
• Financial Dealmakers

Meet key players from across Asia-Pacific, including:

• Australia
• China
• Japan
• India
• South Korea
• Singapore and Southeast Asia

Deliver Thought Leadership

Share your insights, elevate your brand, position yourself as a peer to biopharma decision-makers and investors.

Review sponsorship opportunities >>